Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Obstet Gynecol ; 164(3): 806-12, 1991 Mar.
Article in English | MEDLINE | ID: mdl-2003546

ABSTRACT

In this study the effects of hormone replacement therapy on cardiac function in healthy postmenopausal women were evaluated by Doppler echocardiography that was performed before (T1) and 2.5 months after the initiation of hormone replacement therapy (T2) in the peak estrogenic phase. The following parameters of aortic flow were measured: peak flow velocity, acceleration time, and ejection time. Additional parameters were calculated: flow velocity integral and mean acceleration. The study group included 24 postmenopausal women aged 43 to 60 years (mean 51.6 years). The control group consisted of 19 postmenopausal women aged 46 to 60 years (mean 53.5 years) who were not receiving hormone replacement therapy and who underwent the same evaluation. There were no changes in all Doppler parameters between T1 and T2 in the control group. However, in the study group there were significant increases in peak flow velocity (108.3 +/- 16.7 cm/sec at T1 vs 123 +/- 20.7 cm/sec at T2; p = 0.002), flow velocity integral (17.7 +/- 3.9 vs 21.5 +/- 4.7 cm; p = 0.0003), mean acceleration (11.5 +/- 1.9 vs 13.1 +/- 2.6 m/sec/sec; p = 0.001), and ejection time (324 +/- 37.6 vs 348.8 +/- 40.7 msec; p = 0.002). There was no change in acceleration time (94.8 +/- 6.6 vs 95 +/- 10.9 msec). These results demonstrate that estrogens increase both stroke volume and flow acceleration. The latter probably reflects a combination of enhanced inotropism and vasodilatation. We assume that the cardioprotective effect of hormone replacement therapy in postmenopausal women may be due not only to changes in lipid profile but also to direct effects of estrogens on central and peripheral hemodynamic parameters.


Subject(s)
Aorta/physiology , Echocardiography, Doppler , Estrogen Replacement Therapy , Menopause/physiology , Adult , Blood Flow Velocity/drug effects , Female , Humans , Middle Aged
2.
Am J Obstet Gynecol ; 159(4): 903-5, 1988 Oct.
Article in English | MEDLINE | ID: mdl-3177545

ABSTRACT

Virilizing ovarian tumors are rare and establishing their exact location before operation is difficult. We report a case in which a small left ovarian tumor was seen with magnetic resonance imaging.


Subject(s)
Androgens/metabolism , Leydig Cell Tumor/diagnosis , Magnetic Resonance Imaging , Ovarian Neoplasms/diagnosis , Adult , Female , Humans , Leydig Cell Tumor/complications , Leydig Cell Tumor/metabolism , Ovarian Neoplasms/complications , Ovarian Neoplasms/metabolism , Virilism/etiology
3.
Obstet Gynecol ; 64(5): 621-3, 1984 Nov.
Article in English | MEDLINE | ID: mdl-6493654

ABSTRACT

The effect of lumbar epidural on the course of labor, delivery, and outcome was studied in 115 parturients with a previous cesarean section who were given a trial of vaginal delivery. One hundred three women were multiparous and 12 were grandmultiparous. Uterine contractions and fetal heart rate (FHR) were monitored continuously in all patients. Epidural block was performed using 8 mL of 0.35% bupivacaine without adrenaline. Supplemental doses were administered through an indwelling catheter. At the beginning of the second stage, 10 mL of 0.25% bupivacaine was added in the sitting position. Forty-eight women delivered spontaneously and 54 had an assisted second stage. Thirteen women delivered by a repeat low segmental cesarean section; dehiscence was observed in only one woman. Fetal outcome was satisfactory and similar to that of the authors' general parturient population.


Subject(s)
Anesthesia, Epidural , Anesthesia, Obstetrical , Delivery, Obstetric/methods , Adult , Apgar Score , Bupivacaine/administration & dosage , Cesarean Section , Female , Humans , Infant, Newborn , Labor Stage, Second , Parity , Pregnancy , Reoperation
SELECTION OF CITATIONS
SEARCH DETAIL
...